About Perseus Proteomics
Perseus Proteomics is a company based in Erimo (Japan) founded in 2001 was acquired by Fujifilm in February 2009.. The company has 32 employees as of March 31, 2024. Perseus Proteomics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Erimo, Japan
- Employees 32 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Perseus Proteomics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Perseus Proteomics
Perseus Proteomics is a publicly listed company on the TSE with ticker symbol 4882 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Perseus Proteomics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2006 | Amount | Series A - Perseus Proteomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Perseus Proteomics
Perseus Proteomics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fujifilm. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by the venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Perseus Proteomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Perseus Proteomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perseus Proteomics Comparisons
Competitors of Perseus Proteomics
Perseus Proteomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Perseus Proteomics
Frequently Asked Questions about Perseus Proteomics
When was Perseus Proteomics founded?
Perseus Proteomics was founded in 2001 and raised its 1st funding round 5 years after it was founded.
Where is Perseus Proteomics located?
Perseus Proteomics is headquartered in Erimo, Japan. It is registered at Erimo, Hokkaido, Japan.
How many employees does Perseus Proteomics have?
As of Mar 31, 2024, the latest employee count at Perseus Proteomics is 32.
What is the annual revenue of Perseus Proteomics?
Annual revenue of Perseus Proteomics is $767K as on Mar 31, 2024.
What does Perseus Proteomics do?
Perseus Proteomics was founded in 2001 in Erimo, Japan, within the biotechnology sector. Antibody-based therapeutics and diagnostic reagents are developed for cancer, using disease analysis, transcriptome data, and bioinformatics to target overexpressed surface antigens on malignant cells or blood biomarkers signaling disease states. These tools support drug discovery screening, diagnostic imaging for radiation therapy, antibody-delivered cancer treatments, and biomarker detection for diagnosis, prognosis, and outcome monitoring.
Who are the top competitors of Perseus Proteomics?
Perseus Proteomics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is Perseus Proteomics publicly traded?
Yes, Perseus Proteomics is publicly traded on TSE under the ticker symbol 4882.
Who are Perseus Proteomics's investors?
Perseus Proteomics has 1 investor. Key investors include Fujifilm.
What is Perseus Proteomics's ticker symbol?
The ticker symbol of Perseus Proteomics is 4882 on TSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.